124 related articles for article (PubMed ID: 21919599)
1. Implementation of pharmacogenetics in clinical practice is challenging.
van Schie RM; de Boer A; Maitland-van der Zee AH
Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
[No Abstract] [Full Text] [Related]
2. Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine.
Frueh FW
Pharmacogenomics; 2009 Jul; 10(7):1077-81. PubMed ID: 19604080
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of pharmacogenetics: present and near future.
Gladding PA
Cleve Clin J Med; 2013 Aug; 80(8):477-82. PubMed ID: 23908102
[No Abstract] [Full Text] [Related]
4. Targeted medications. New focus on companion tests.
Reinke T
Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
[No Abstract] [Full Text] [Related]
5. [Pharmacogenomics: hype or hope?].
Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
[TBL] [Abstract][Full Text] [Related]
6. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
Steen VD
Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
[No Abstract] [Full Text] [Related]
7. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
Lesko LJ; Zineh I
Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
[TBL] [Abstract][Full Text] [Related]
8. How genetic variation affects patient response and outcome to therapy for psoriasis.
Woolf RT; Smith CH
Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
[TBL] [Abstract][Full Text] [Related]
9. Innovations driving biomarker evaluation and use.
Wagner JA
Biomark Med; 2010 Dec; 4(6):779-81. PubMed ID: 21133694
[No Abstract] [Full Text] [Related]
10. Next-generation medicines: past regulatory experience and considerations for the future.
Pacanowski MA; Leptak C; Zineh I
Clin Pharmacol Ther; 2014 Mar; 95(3):247-9. PubMed ID: 24548989
[TBL] [Abstract][Full Text] [Related]
11. Where are we today with personalized medicine?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
[TBL] [Abstract][Full Text] [Related]
12. Company profile: PGXIS Ltd.
McCarthy A
Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
[TBL] [Abstract][Full Text] [Related]
13. [Personalized medicine on the upswing].
Saussele T
Med Monatsschr Pharm; 2014 Mar; 37(3):81. PubMed ID: 24741847
[No Abstract] [Full Text] [Related]
14. Clinical drug tests adapted for speed.
Ledford H
Nature; 2010 Apr; 464(7293):1258. PubMed ID: 20428134
[No Abstract] [Full Text] [Related]
15. [Genome analysis - what does the future hold, what is science fiction? Interview by Prof. Dr. med. Johann Steurer].
Hafen E; Roose A
Praxis (Bern 1994); 2012 Jul; 101(15):971-4. PubMed ID: 22811330
[No Abstract] [Full Text] [Related]
16. Good genes. Are we ready for inexpensive, easy access to personal DNA tests?
Rochman B
Time; 2012 Aug; 180(8):14. PubMed ID: 22950259
[No Abstract] [Full Text] [Related]
17. [Pharmacogenetics: current state after 30 years of research].
Eichelbaum M
Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369
[No Abstract] [Full Text] [Related]
18. [Pharmacogenetics and the hospital pharmacy].
Aldaz A
Farm Hosp; 2011; 35(4):163-4. PubMed ID: 21741871
[No Abstract] [Full Text] [Related]
19. With your genes? Take one of these, three times a day.
Abbott A
Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
[No Abstract] [Full Text] [Related]
20. What is clinical utility and why should we care?
Lesko LJ; Zineh I; Huang SM
Clin Pharmacol Ther; 2010 Dec; 88(6):729-33. PubMed ID: 21081937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
